Publications by authors named "Jacqueline Cloos"

100Publications

DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery.

Genomics Proteomics Bioinformatics 2020 Aug 12. Epub 2020 Aug 12.

Zhejiang Provincial Laboratory of Life Sciences and Biomedicine, Westlake University, Hangzhou 310024, China; Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gpb.2019.11.008DOI Listing
August 2020

Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.

Nucleosides Nucleotides Nucleic Acids 2020 Jul 30:1-12. Epub 2020 Jul 30.

Laboratory Medical Oncology, Amsterdam UMC, location VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15257770.2020.1780441DOI Listing
July 2020

Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

Nucleosides Nucleotides Nucleic Acids 2020 Apr 20:1-10. Epub 2020 Apr 20.

Laboratory Medical Oncology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15257770.2020.1746803DOI Listing
April 2020

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.

Pathology 2020 02 26;52(2):289-291. Epub 2019 Dec 26.

Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2019.09.021DOI Listing
February 2020

Minimal residual disease and stem cell transplantation outcomes.

Hematology Am Soc Hematol Educ Program 2019 12;2019(1):617-625

Department of Medical and Molecular Genetics, King's College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/hematology.2019000006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913494PMC
December 2019

Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.

Curr Protoc Cytom 2019 12;91(1):e66

Department of Hematology, Amsterdam University Medical Center, Cancer Center VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpcy.66DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856793PMC
December 2019

TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia.

Br J Haematol 2020 Mar 6;188(5):736-739. Epub 2019 Oct 6.

Department of Paediatric Oncology, Cancer Centre Amsterdam, Amsterdam UMC, VUMC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16229
Publisher Site
http://dx.doi.org/10.1111/bjh.16229DOI Listing
March 2020

Can we incorporate MRD assessment into clinical practice in AML?

Best Pract Res Clin Haematol 2019 06 10;32(2):186-191. Epub 2019 May 10.

Amsterdam University Medical Center, Location VUMC, De Boelelaan 1117, 1081, HV, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.05.003DOI Listing
June 2019

Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.

Leuk Res 2019 06 9;81:27-34. Epub 2019 Apr 9.

Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, 1081HV Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.04.004DOI Listing
June 2019

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.

EBioMedicine 2019 Jan 20;39:215-225. Epub 2018 Dec 20.

Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, location VUMC, Amsterdam, the Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Italy; CNR-Nano, Institute of Nanoscience and Nanotechnology, Pisa, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964183060
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2018.12.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355829PMC
January 2019

Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization.

Expert Rev Hematol 2018 12;11(12):921-935

a Department of Hematology , VU University Medical Center , Amsterdam , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1549479DOI Listing
December 2018

MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles.

Radiology 2018 08 1;288(2):506-515. Epub 2018 May 1.

From the Departments of Radiology and Nuclear Medicine (R.W.J., M.C.d.J., J.A.C., P.d.G.), Clinical Genetics (I.E.K., J.C.D.), Ophthalmology (A.C.M.), Pathology (P.v.d.V.), Pediatric Oncology (J.C.), and Epidemiology and Biostatistics (I.E.), VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, the Netherlands; European Retinoblastoma Imaging Collaboration (ERIC) (R.W.J., M.C.d.J., S.S., S.G., H.J.B., P.M., P.G., J.A.C., P.d.G.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.S., S.G.); Department of Radiology, Institut Curie, Paris, France and Paris Sciences et Lettres Research University, Paris, France (H.J.B.); Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland (P.M.); and Unit of Neuroimaging and Neurointervention, Department of Neurosciences, Siena University Hospital, Siena, Italy (P.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018172000DOI Listing
August 2018

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

N Engl J Med 2018 Mar;378(13):1189-1199

From the Department of Hematology (M.J.-L., T.G., F.G.K., A.H., A.Z., C.A.J.E.-V., M.A.S., B.L., P.J.M.V.) and HOVON Data Center, Department of Hematology (P.L.G., R.M.), Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, the Department of Hematology, VU University Medical Center (D.H., J.C., G.J.O., G.J.S.), and the Department of Hematology, Academic Medical Center (B.J.B.), Amsterdam, and Isala Hospital, Zwolle (M.M.K.) - all in the Netherlands; UCL Namur (Godinne), Yvoir (C.G.), and the Department of Hematology, Cliniques Universitaires Saint-Luc, Brussels (V.H.) - both in Belgium; and the Department of Hematology, University Hospital Zurich, Zurich (M.G.M.), University Hospital, Bern (T.P.), and the Division of Hematology, University Hospital Basel, Basel (J.R.P.) - all in Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716863DOI Listing
March 2018

Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide.

Invest New Drugs 2018 10 14;36(5):797-809. Epub 2018 Feb 14.

Departments of Rheumatology, Amsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Rm 2.46, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0569-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153520PMC
October 2018

Positioning of proteasome inhibitors in therapy of solid malignancies.

Cancer Chemother Pharmacol 2018 02 28;81(2):227-243. Epub 2017 Nov 28.

Amsterdam Rheumatology and Immunology Center, Location VUmc, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3489-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778165PMC
February 2018

Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma.

Oncotarget 2017 Oct 8;8(45):78978-78988. Epub 2017 Sep 8.

Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20741DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668013PMC
October 2017

(Immuno)proteasomes as therapeutic target in acute leukemia.

Cancer Metastasis Rev 2017 12;36(4):599-615

Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-017-9699-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721123PMC
December 2017

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis.

Cancer Metab 2017 29;5. Epub 2017 Aug 29.

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40170-017-0169-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575874PMC
August 2017

The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia.

Cytometry B Clin Cytom 2018 01 15;94(1):151-158. Epub 2017 Aug 15.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21539DOI Listing
January 2018

Leukemic stem cells: identification and clinical application.

Int J Hematol 2017 May 29;105(5):549-557. Epub 2017 Mar 29.

Department of Hematology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2221-5DOI Listing
May 2017

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models.

J Vis Exp 2016 12 9(118). Epub 2016 Dec 9.

Department of Medical Oncology, VU University Medical Center; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa; Institute of Nanoscience and Nanotechnology, CNR-Nano;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/54714DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226372PMC
December 2016

Genomic landscape of retinoblastoma in Rb p130 mice resembles human retinoblastoma.

Genes Chromosomes Cancer 2017 03 21;56(3):231-242. Epub 2016 Nov 21.

Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081BT, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22429DOI Listing
March 2017

The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia.

Haematologica 2016 07 1;101(7):e291-4. Epub 2016 Apr 1.

Dept of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands Dept. of Hematology, VU University Medical Center, Amsterdam, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.142794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004475PMC
July 2016

CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia.

Br J Haematol 2016 Apr 27;173(2):219-35. Epub 2016 Jan 27.

Department of Haematology, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13941DOI Listing
April 2016

Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.

J Clin Oncol 2015 Dec 16;33(36):4247-58. Epub 2015 Nov 16.

Kim Klein, Gertjan Kaspers, Jacqueline Cloos, and Mathilda Bongers, Vrije Universiteit University Medical Center Amsterdam; Gertjan Kaspers and Ardine Reedijk, Dutch Childhood Oncology Group, The Hague; H. Berna Beverloo, Erasmus Medical Center, Rotterdam, the Netherlands; Christine J. Harrison, Newcastle University, Newcastle upon Tyne; Brenda Gibson, Royal Hospital for Sick Children, Glasgow, United Kingdom; Andrea Pession, Italian Association of Pediatric Hematology Oncology, Bologna, Italy; Dirk Reinhardt, Berlin-Frankfurt-Münster (BFM) -Germany, Essen; Martin Zimmerman and Ursula Creutzig, BFM-Germany, Hannover, Germany; Michael Dworzak, BFM-Austria, Vienna, Austria; Todd Alonzo, Donna Johnston, and Betsy Hirsch, Children's Oncology Group (COG) including Children's Cancer Group and Pediatric Oncology Group, Philadelphia (COG chair's office), PA; Michal Zapotocky, Czech Paediatric Hematology Working Group, Prague, Czech Republic; Barbara De Moerloose, European Organisation for Research and Treatment of Cancer-Children's Leukemia Group, Brussels, Belgium; Alcira Flynn, Grupo Argentino de Tratamiento de la Leucemia Aguda, Buenos Aires, Argentina; Vincent Lee, Hong Kong Paediatric Haematology and Oncology Study Group, Hong Kong, Special Administrative Region, People's Republic of China; Takashi Taga, Japanese Pediatric Leukemia/Lymphoma Study Group, Otsu; Akio Tawa, Japanese Pediatric Leukemia/Lymphoma Study Group, Osaka, Japan; Anne Auvrignon, French Leucémie Aiguë Myéloblastique Enfant Cooperative Group, Paris, France; Bernward Zeller, Nordic Society of Paediatric Haematology and Oncology, Oslo, Norway; Erik Forestier, Nordic Society of Paediatric Haematology and Oncology, Umeå, Sweden; Carmen Salgado, The National Program for Antineoplastic Drugs for Children, Santiago, Chile; Walentyna Balwierz, Polish Pediatric Leukemia Lymphoma Study Group, Krakow, Poland; Alexander Popa, Russian Acute Myeloid Leukemia Study Group, Moscow, Russia; and Jeffrey Rubnitz and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321085PMC
December 2015

Absence of leukaemic CD34 cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered.

Br J Haematol 2015 Oct 24;171(2):227-238. Epub 2015 Jun 24.

Department of Haematology, VU University Medical Centre, Cancer Centre Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13572DOI Listing
October 2015

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia.

J Hematol Oncol 2015 May 29;8:61. Epub 2015 May 29.

Department of Pediatric Oncology/Hematology, VUmc Cancer Center Amsterdam, VU University Medical Center, Room CCA 4.28, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.jhoonline.org/content/8/1/61
Publisher Site
http://dx.doi.org/10.1186/s13045-015-0158-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455979PMC
May 2015

Gene expression profiles associated with pediatric relapsed AML.

PLoS One 2015 7;10(4):e0121730. Epub 2015 Apr 7.

Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121730PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388534PMC
March 2016

Molecular basis of resistance to proteasome inhibitors in hematological malignancies.

Drug Resist Updat 2015 Jan 10;18:18-35. Epub 2014 Dec 10.

Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands; Hematology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2014.12.001DOI Listing
January 2015

Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.

Expert Opin Drug Metab Toxicol 2015 May 13;11(5):673-89. Epub 2014 Dec 13.

VU University Medical Center, Department of Pediatric Oncology/Hematology , Amsterdam , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2015.993316DOI Listing
May 2015

Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.

Expert Rev Hematol 2014 Dec 22;7(6):791-805. Epub 2014 Sep 22.

Departments of Pediatric Oncology/Hematology and Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.959921DOI Listing
December 2014

Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse.

Br J Haematol 2014 Sep 25;166(6):902-10. Epub 2014 Jun 25.

Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands; Department of Paediatric Oncology/Haematology, VU University Medical Centre, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12989DOI Listing
September 2014

Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib).

Mol Pharmacol 2014 Jul 15;86(1):12-9. Epub 2014 Apr 15.

Department of Pediatric Oncology/Hematology (D.N., L.F.V.R., J.v.M., G.J.L.K., J.C.), Department of Rheumatology (G.J.), and Department of Hematology (J.v.M., S.Z., J.C.), VU University Medical Center, Amsterdam, The Netherlands; Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, San Diego, California (A.J.K., B.S.M.); The Fred Wyszkowski Cancer Research Laboratory, Technion-Israel Institute of Technology, Haifa, Israel (Y.G.A.); and Research Department, Onyx Pharmaceuticals Inc., South San Francisco, California (J.L.A.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.114.092114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054006PMC
July 2014

RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients.

J Med Genet 2014 Jun 31;51(6):366-74. Epub 2014 Mar 31.

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2014-102264DOI Listing
June 2014

Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924.

Biochem Pharmacol 2014 May 16;89(1):43-51. Epub 2014 Feb 16.

Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2014.02.005DOI Listing
May 2014

How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?

Transl Pediatr 2013 Apr;2(2):80-3

1 Department of Haematology, 2 Department of Haematology and Pediatric Oncology/Haematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2224-4336.2013.04.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728920PMC
April 2013

Proteasome inhibitors in acute leukemia.

Expert Rev Anticancer Ther 2013 Mar;13(3):327-37

Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.4DOI Listing
March 2013

Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.

J Blood Med 2013 1;4:1-9. Epub 2013 Feb 1.

Pediatric Hematology and Oncology Division, Department of Pediatrics, Dr Sardjito Hospital, Medical Faculty, Universitas Gadjah Mada, Yogyakarta, Indonesia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JBM.S33906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565570PMC
February 2013

Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol.

J Oncol 2012 26;2012:135186. Epub 2012 Nov 26.

Pediatric Hematology Oncology Division, Department of Pediatrics, Dr. Sardjito Hospital, Faculty of Medicine, Universitas Gadjah Mada, Jl. Kesehatan No. 1, Yogyakarta 55281, Indonesia.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jo/2012/135186/
Publisher Site
http://dx.doi.org/10.1155/2012/135186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513752PMC
December 2012

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.

Oncotarget 2011 Dec;2(12):984-96

Department of Pediatric Oncology / Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282104PMC
http://dx.doi.org/10.18632/oncotarget.362DOI Listing
December 2011

Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998-2009.

Pediatr Blood Cancer 2011 Oct 16;57(4):588-93. Epub 2011 Jun 16.

Pediatric Hematology Oncology Division, Department of Pediatrics, Dr. Sardjito Hospital, Medical Faculty, Universitas Gadjah Mada, Yogyakarta, Indonesia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.23109
Publisher Site
http://dx.doi.org/10.1002/pbc.23109DOI Listing
October 2011

Cell sensitivity assays: the MTT assay.

Methods Mol Biol 2011 ;731:237-45

Department of Paediatric Oncology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-61779-080-5_20
Publisher Site
http://dx.doi.org/10.1007/978-1-61779-080-5_20DOI Listing
August 2011

Immunophenotypic patterns of childhood acute leukemias in Indonesia.

Asian Pac J Cancer Prev 2011 ;12(12):3381-7

Department of Pediatrics, Universitas Gadjah Mada, Yogyakarta, Indonesia.

View Article

Download full-text PDF

Source
August 2012

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.

Blood 2010 Sep 3;116(10):1747-54. Epub 2010 Jun 3.

Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-03-270991DOI Listing
September 2010

Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).

Anticancer Agents Med Chem 2009 Feb;9(2):212-20

Department of Pediatric Oncology/Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152009787313864DOI Listing
February 2009

Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.

Leuk Res 2008 Jan 28;32(1):19-24. Epub 2007 Mar 28.

Department of Medical Oncology, VU Institute for Cancer and Immunology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521260700081
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2007.02.011DOI Listing
January 2008